8月21日，由DT新材料主办，北京大学宁波海洋药物研究院、宁波酶赛生物工程有限公司共同协办的 第四届合成生物与绿色生物制造大会 （简称： SynBioCon 2025）在宁波隆重开幕！ 本届大会共出席 60+ 专家和企业高层，分享 40+ 场精彩报告。大会涵盖四大专场：生物制造宏观论坛、绿色化工和新材料专场、人工智能在生物制造 领域典型应用案例推广系列活动暨 AI赋能生物制造产业创新发 展、未来食品&农业专场。同期举 办生物制造青年论坛、生物制造产业高层座谈会（第三 期）、《2025人工智能赋能生物制造产业创新发展蓝皮书》闭门研讨会、合成生物科技成果对接等活动。 开幕式&签约仪式 8月21日上午，DT新材料CEO 张立生 开幕主持。 宁波市鄞州区委副书记 余宁 为大 会致开幕 辞。 余宁表示鄞州未来将重点做好三个方面：一是 加快建设鄞州生物医药创新园 ，全力推动浙江省医疗器械检验研究院宁波院区等一批创新平台落地。二是 聚焦生物医药、生物材料、生物农业等重点领域 ，挖掘和培育一批瞪羚企业（指高成长中小企业）、准独角兽企业。三是强化产业基金对合成生物领域 投资力度，努力为产业发展营造最富吸引力、最具竞争力的环境 ...

Core Business Strategy - The company will firmly implement the "231" industrial development strategy, focusing on "animal nutrition, food seasoning, and value chain extension" as its two core businesses [1] - The company aims to strengthen its animal nutrition, food additives, and seasoning sectors while promoting breakthroughs in three innovative fields: biomedicine, human nutrition and health, and plant nutrition [1] Financial Performance - In 2024, the company achieved operating revenue of 17.334 billion yuan and a net profit attributable to shareholders of 943 million yuan, representing a year-on-year growth of 39.12% [1] - In the first quarter of 2025, the company reported operating revenue of 4.039 billion yuan and a net profit attributable to shareholders of 474 million yuan, showing a year-on-year increase of 88.55% [1] Production Capacity and Market Position - The company ranks among the top producers globally in core products such as lysine, threonine, monosodium glutamate, and nucleotides, with both production capacity and technology levels leading the industry [1] - The company is investing in a 600,000-ton corn deep processing and cogeneration project in Xinjiang, which is currently under construction and will primarily produce small-volume amino acid products [2] Project Investments - The company plans to invest no more than 3.3 billion yuan in a 450,000-ton amino acid and supporting engineering project, with funding sourced from its own capital and bank loans, each accounting for approximately 50% [2] - The construction period for the amino acid project is expected to be 22 months [2] Market Conditions - The company acknowledges that product sales prices are influenced by raw material costs, market supply and demand, and industry competition, leading to some volatility [2] - The company is focused on enhancing product competitiveness through cost reduction and efficiency improvement, leveraging its large-scale production capabilities [2]

Core Viewpoint - The company is facing challenges in its amino acid project due to low profit margins and rising raw material costs, but it remains committed to its strategic investments to strengthen its market position [2][5][7]. Group 1: Company Performance - As of June 27, 2025, the company's stock price closed at 6.93 yuan, down 5.46% from the previous week, with a total market capitalization of 11.514 billion yuan [1]. - The company reported a year-on-year increase of 23.97% in cash balance, reaching 1.759 billion yuan by the end of 2024 [8][9]. Group 2: Strategic Investments - The company is investing over 3 billion yuan in a 450,000-ton amino acid project, which currently has a profit margin of only 10%, to consolidate its industry position [2][5][7]. - A 600,000-ton corn deep processing project in Xinjiang is under construction, with an expected completion date in 2026 [7]. Group 3: Market Challenges - The company is experiencing intense competition in the market, particularly with its subsidiary Sichuan Jiuling Pharmaceutical, which has contributed minimally to overall performance [3][4]. - The company acknowledges the volatility in product pricing and raw material costs, which affects profit margins [7]. Group 4: Future Outlook - The company is focused on high-quality development and is exploring new technologies and markets, including biopharmaceuticals and new materials [4][6]. - The company plans to enhance its competitive advantages and market presence through strategic investments and operational improvements [6][9].

截至2025年4月30日收盘，星湖科技(600866)报收于7.56元，下跌1.05%，换手率3.45%，成交量38.24万 手，成交额2.92亿元。 董秘最新回复 投资者： 去年请问出口美国收入多少？ 董秘： 尊敬的投资者，您好！在国际市场上，公司产品远销欧洲、东南亚、韩国等50多个国家与地 区，公司2024年度国外整体销售收入情况请详见公司于2025年4月22日在上海证券交易所披露的临2025- 011号《2024年度主要经营数据公告》。感谢您的关注！ 投资者： 请问，截止4月25日收盘，股东户数多少？ 董秘： 尊敬的投资者，您好！关于公司的股东户数请详见公司于2025年4月22日在上海证券交易所披露 的《2025年第一季度报告》，感谢您的关注！ 投资者： 董秘您好，根据美国对中国的最新关税政策，对公司影响有多大，是否可以进行成本转移， 公司对美国出口的营业收入占比有多少，未来对美业务规划如何。 董秘： 尊敬的投资者，您好！在国际市场上，公司产品远销欧洲、东南亚、韩国等50多个国家与地 区，目前美国对中国的关税政策不会对公司的生产经营产生重大影响。公司将密切关注国际经济环境及 相关政策的变化，积极研究和制 ...

涉及总金额11 8 4 . 9 9 亿元人民币。 作者 | 私募通 报道 | 决策投资圈 （ID： PEDATAMAX） 清科创业（0 1 9 4 5 .HK）旗下私募通统计：截至本周四下午，募资、投资、上市和并购共 1 3 9 起 事 件 ， 涉 及 总 金 额 1184.99 亿 人 民 币 。 从 交 易 金 额 来 看 ， 本 周 金 额 较 大 事 件 是 ： 2 0 25年3月3 1日，赛力斯集团股份有限公司成功受让华为技术有限公司持有的深圳引望 智能技术有限公司的10.0%的股权，作价11 5 . 0 0亿人民币。从交易事件地域分布看，目 前主要分布在广东省、江苏省和浙江省，占比为广东省16.7%，江苏省15.2%，浙江省 占13.6%。 更多信息请登录：h tt p s://ma x.pe da t a . c n/ 本周募资情况 本周新登记股权投资基金管理人共计4家，取消备案登记1家，全年截至目前累计股权投 资基金管理人数量为2 1家。本周新增备案基金数量为73只，规模总计936.86亿元，本周 备案基金募资最多的为国家军民融合产业投资基金二期有限责任公司，募集596.00亿人 民 币 。 ...